Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Farkhondeh, Atena  [Clear All Filters]
2021
Brooks BM, Pradhan M, Cheng Y-S, Gorshkov K, Farkhondeh A, Chen CZ, Beers J, Liu C, Baumgaertel K, Rodems S, et al. Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1. Stem Cell Res. 2021;54:102447.
Pavlinov I, Farkhondeh A, Yang S, Xu M, Cheng Y-S, Beers J, Zou J, Liu C, Might M, Rodems S, et al. Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9. Stem Cell Res. 2021;56:102554.
Pradhan M, Farkhondeh A, Cheng Y-S, Xu M, Beers J, Zou J, Liu C, Might M, Rodems S, Baumgärtel K, et al. An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene. Stem Cell Res. 2021;54:102400.
2019
Farkhondeh A, Li R, Gorshkov K, Chen KG, Might M, Rodems S, Lo DC, Zheng W. Induced pluripotent stem cells for neural drug discovery. Drug Discov Today. 2019.
2018
Li R, Pradhan M, Xu M, Baskfield A, Farkhondeh A, Cheng Y-S, Beers J, Zou J, Liu C, Might M, et al. Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene. Stem Cell Res. 2018;34:101362.